ACQUISITION OF ACTIENT (Tables)

6 Months Ended

Jun. 30, 2013

ACQUISITION OF ACTIENT

Summary of fair value of the total consideration

The following table summarizes the fair value of the total consideration at April 26, 2013:

	Total
	Acquisition-
	Date
	Fair value
Base cash consideration	$	585,000
Cash and working capital adjustment	15,431
Contingent consideration	40,958
Warrants	12,000
Total consideration	653,389
Consideration representing compensation	(8,309		)
Consideration allocated to net assets acquired	$	645,080

Summary of fair value of net assets acquired

	April 26,
	2013
Cash	$	11,514
Accounts recievable, trade	25,631
Inventory	21,704
Prepaid expenses and other current assets	4,061
Property and equipment	3,028
Purchased intangibles	667,000
Goodwill	113,369
Other long-term assets	6,116
Total assets acquired	852,423
Contingent consideration assumed	(72,900		)
Other liabilities assumed	(29,906		)
Deferred tax liabilities	(104,537		)
Total net assets acquired	$	645,080

Summary of fair value assigned to product rights acquired and the amortization period assigned to these rights

	Fair value		Estimated life in years
TESTOPEL	$	491,000	12
Edex	70,000		11
Timm Medical	23,000		10
Striant	8,000		10
Theo-24	39,000		9
Semprex-D	32,000		10
Other products	4,000		2
Total	$	667,000

Schedule of pro forma results of operations

	Unaudited pro forma consolidated results
	Three months ended June 30,						Six months ended June 30,
	2013			2012			2013			2012
Net revenues	$	115,113		$	108,620		$	215,830		$	212,129
Net income (loss) attributable to the Company	$	(33,964	)	$	(23,349	)	$	(36,612	)	$	19,388
Net income (loss) per common share-
Basic	$	(0.69	)	$	(0.48	)	$	(0.74	)	$	0.40
Diluted	$	(0.69	)	$	(0.47	)	$	(0.74	)	$	0.39